orphelia-pharma.eu valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.orphelia-pharma.eu/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | ORPHELIA Pharma - Medicines for rare |
| Description | ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of rare diseases, with formulations adapted to the pediatric |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 217.70.184.38 |
| Location | France |
Related Websites
| Site | Rank |
More to Explore
orphelia-pharma.eu Valuation
|
US$3,302,112
Last updated: 2023-05-13 10:31:04
orphelia-pharma.eu has Semrush global rank of 3,205,314. orphelia-pharma.eu has an estimated worth of US$ 3,302,112, based on its estimated Ads revenue. orphelia-pharma.eu receives approximately 381,013 unique visitors each day. Its web server is located in France, with IP address 217.70.184.38. According to SiteAdvisor, orphelia-pharma.eu is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,302,112 |
| Daily Ads Revenue | US$3,049 |
| Monthly Ads Revenue | US$91,444 |
| Yearly Ads Revenue | US$1,097,317 |
| Daily Unique Visitors | 25,401 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| orphelia-pharma.eu. | A | 10797 | IP: 217.70.184.38 |
| orphelia-pharma.eu. | NS | 10800 | NS Record: ns-59-a.gandi.net. |
| orphelia-pharma.eu. | NS | 10800 | NS Record: ns-232-c.gandi.net. |
| orphelia-pharma.eu. | NS | 10800 | NS Record: ns-138-b.gandi.net. |
| orphelia-pharma.eu. | MX | 3600 | MX Record: 10 orpheliapharma-eu02b.mail.protection.outlook.com. |
| orphelia-pharma.eu. | TXT | 3600 | TXT Record: MS=ms63469017 |
| orphelia-pharma.eu. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com a:eudralink1.ema.europa.eu a:eudralink.ema.europa.eu a:fw-orange.offc.orphelia-pharma.eu -all |
HtmlToTextCheckTime:2023-05-13 10:31:04
| ORPHELIA Pharma Therapeutic Areas Products Kigabeq Kimozo Ivozall Partners Careers News Contact × ORPHELIA Pharma Therapeutic Areas Products Kigabeq Kimozo Ivozall Partners Careers News Contact Medicines for rare diseases Discover ORPHELIA Pharma Development of essential medicines in the field of rare and pediatric diseases. Read more Discover Products & Projects Focus on deadly epileptic childhood syndromes and refractory and relapsed pediatric cancers. therapeutics areas Latest news Visit our news flow to access our press release and latest news. 9 May 2023 Event : ANR 2023 (15-18 May, Amsterdam, the Netherlands) Read More 2 May 2023 Event : SIOPe (May 8-12, Valencia, Spain) Read More 18 April 2023 ORPHELIA Pharma selects Tanner Pharma to Initiate Named Patient Program for KIMOZO® Read More ORPHELIA Pharma – 85 boulevard Saint Michel, 75005 Paris – France + 33 (0)1 42 77 08 18 – contact@orphelia-pharma.eu Politique de confidentialité Data privacy policy × Politique de |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Tue, 21 Dec 2021 05:57:18 GMT Content-Type: text/html Connection: close Location: http://www.orphelia-pharma.eu Cache-Control: max-age=10800 Vary: Accept-Language HTTP/1.1 301 Moved Permanently date: Tue, 21 Dec 2021 05:57:19 GMT content-type: text/html; charset=UTF-8 server: Apache x-powered-by: PHP/7.3 x-redirect-by: WordPress location: https://www.orphelia-pharma.eu/ x-iplb-request-id: 425E6E4A:81EA_D5BA2110:0050_61C16CBE_88AA:24351 x-iplb-instance: 28102 HTTP/2 200 date: Tue, 21 Dec 2021 05:57:20 GMT content-type: text/html; charset=UTF-8 server: Apache x-powered-by: PHP/7.3 vary: Accept-Encoding |
orphelia-pharma.eu Whois Information
Domain: orphelia-pharma.eu Script: LATIN NOT DISCLOSED! Visit www.eurid.eu for webbased WHOIS. Organisation: Gandi SAS Language: fr Email: eu-tech@gandi.net Name: GANDI Website: https://www.gandi.net ns-59-a.gandi.net ns-232-c.gandi.net ns-138-b.gandi.net Please visit www.eurid.eu for more info. |